RAPP
Rapport Therapeutics, Inc. · Healthcare
Chief Executive Officer Abraham Ceesay sold $374K of Rapport Therapeutics, Inc.
Sold$374,498
$45.61Price
8,210Shares
−2%Stake
What RAPP did after the filing
- The stock from Thu, Sep 10 open, $43.35
- −38.8%
- S&P 500, same days
- +0.8%
Measured over 30 trading days, to the Oct 22 close.
Traded Tue, Sep 8. Filed Wed, Sep 9, 4:05 PM ET, after the close. Returns use the Sep 10 open and the Oct 22 close. Not investment advice.